Lanean...

In vivo delivery of siRNA targeting vasohibin‐2 decreases tumor angiogenesis and suppresses tumor growth in ovarian cancer

Vasohibin‐2 (VASH2) is a homolog of vasohibin‐1 and exhibits pro‐angiogenic activity. We recently reported that VASH2 is expressed in certain ovarian cancers and promotes tumor growth through angiogenesis. To further demonstrate the effectiveness of molecular targeting of VASH2 for anticancer treatm...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Sci
Egile Nagusiak: Koyanagi, Takahiro, Suzuki, Yasuhiro, Saga, Yasushi, Machida, Shizuo, Takei, Yuji, Fujiwara, Hiroyuki, Suzuki, Mitsuaki, Sato, Yasufumi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2013
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7654253/
https://ncbi.nlm.nih.gov/pubmed/24118388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12297
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!